Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study

Ho FK. et al, (2024), PLoS Medicine, 21

2024 ESC Guidelines for the management of elevated blood pressure and hypertension.

McEvoy JW. et al, (2024), Eur Heart J

Emerging role of incretin-based therapy as first-line antihypertensives in obesity.

Rahimi K., (2024), Heart

Blood pressure management in type 2 diabetes: a review of recent evidence.

Wamil M. et al, (2024), Heart

Mounting evidence in favour of the lower, the better blood pressure paradigm.

Rahimi K., (2024), Lancet

Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study

Conrad N. et al, (2024), BMJ, e078523 - e078523

Centennial Collection: From Treating Hypertension to Lowering Cardiovascular Disease Risk.

McCarthy CP. et al, (2024), Hypertension

Self-Administration of Aspirin After Chest Pain for the Prevention of Premature Cardiovascular Mortality in the United States: A Population-Based Analysis.

Russo RG. et al, (2024), J Am Heart Assoc

Targeted-BEHRT: Deep Learning for Observational Causal Inference on Longitudinal Electronic Health Records.

Rao S. et al, (2024), IEEE Trans Neural Netw Learn Syst, 35, 5027 - 5038

For Heart: the journey at the forefront of cardiovascular medicine continues.

Rahimi K., (2023), Heart, 110, 1 - 2

Antihypertensive Treatment Evaluation in Multimorbidity and Polypharmacy Trial (ATEMPT): A decentralised open-label pilot trial

Majert J. et al, (2023), The Lancet. Healthy Longevity

Asynchronous communication for medical journal editorial teams in a diverse global research community.

Otto CM. et al, (2023), Heart, 109, 1802 - 1804

Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis

Bidel Z. et al, (2023), Hypertension, 80, 2293 - 2302

The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis.

Ciofani JL. et al, (2023), Sci Rep, 13

Prognosis, characteristics, and provision of care for patients with the unspecified heart failure electronic health record phenotype: a population-based linked cohort study of 95262 individuals

Nakao YM. et al, (2023), eClinicalMedicine, 63

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.

Rao S. et al, (2023), Eur Heart J

A comparative study of model-centric and data-centric approaches in the development of cardiovascular disease risk prediction models in the UK Biobank.

Mamouei M. et al, (2023), Eur Heart J Digit Health, 4, 337 - 346

Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis.

Wamil M. et al, (2023), Sci Rep, 13

The Effect of Immunomodulatory Drugs on Aortic Stenosis: A Mendelian Randomisation Analysis

Ciofani J. et al, (2023), Heart, Lung and Circulation, 32, S317 - S317

Long-Term Exposure to Road Traffic Noise and Incident Heart Failure: Evidence From UK Biobank.

Yang T. et al, (2023), JACC Heart Fail

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?